News | October 09, 2023
Mitsui invests in Lokavant Holdings
Lokavant provides clinical trial intelligence
Lokavant provides clinical trial intelligence
Advances Amgen's mission to serve patients with rare disease medicines
NRT offers 50% higher success rate in quitting smoking compared to unassisted attempts
This integrated care offering is a step forward in our vision of providing an effective continuum of care for patients
The approval adds to a list of products that Strides has approved in this therapeutic category through the PEPFAR pathway taking the total to 15 products
The introduction of 'Definisse Core Filler' is a testament to the company's premium scientific-based innovation
WINLEVI works differently from any other topical acne treatment
Glenmark will receive from Cassiopea, a subsidiary of Cosmo, the exclusive right to commercialize Winlevi in 15 EU countries
Also to be launched Scheme for promotion of Research and Innovation in Pharma MedTech Sector (PRIP)
The companies will work with investigators to share the results with the scientific community
Subscribe To Our Newsletter & Stay Updated
